(-0.19%) 5 202.75 points
(-0.14%) 39 139 points
(-0.27%) 18 137 points
(0.66%) $79.51
(-0.18%) $2.18
(-0.19%) $2 317.80
(0.76%) $27.81
(0.53%) $989.80
(0.19%) $0.932
(0.23%) $10.92
(0.18%) $0.802
(0.50%) $92.19
Live Chart Being Loaded With Signals
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc...
Stats | |
---|---|
Today's Volume | 1 063.00 |
Average Volume | 0.00 |
Market Cap | 101.08M |
EPS | INR7.99 ( 2022-03-31 ) |
Last Dividend | INR1.125 ( 2010-09-13 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -0.110 |
ATR14 | INR0.0200 (0.69%) |
Volume Correlation
Parenteral Drugs (India) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Parenteral Drugs (India) Correlation - Currency/Commodity
Parenteral Drugs (India) Financials
Annual | 2022 |
Revenue: | INR84.96M |
Gross Profit: | INR30.31M (35.67 %) |
EPS: | INR-25.61 |
FY | 2022 |
Revenue: | INR84.96M |
Gross Profit: | INR30.31M (35.67 %) |
EPS: | INR-25.61 |
FY | 2021 |
Revenue: | INR121.53M |
Gross Profit: | INR48.37M (39.80 %) |
EPS: | INR-40.82 |
FY | 2020 |
Revenue: | INR240.25M |
Gross Profit: | INR13.40M (5.58 %) |
EPS: | INR-38.26 |
Financial Reports:
No articles found.
Parenteral Drugs (India) Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR1.125 | 2010-09-13 |
Last Dividend | INR1.125 | 2010-09-13 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | INR1.125 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0.0762 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TNPETRO.NS | Dividend Junior | 2023-09-18 | Sporadic | 23 | 2.02% | |
PFC.NS | Dividend King | 2023-06-16 | Quarterly | 18 | 7.12% | |
JASH.NS | Dividend Junior | 2023-09-22 | Annually | 7 | 0.57% | |
DBOL.NS | Dividend Junior | 2023-06-23 | Insufficient data to determine frequency | 2 | 0.56% | |
SIYSIL.NS | Dividend Junior | 2023-07-24 | Semi-Annually | 18 | 1.37% | |
MBAPL.NS | Dividend Junior | 2023-09-18 | Annually | 8 | 0.44% | |
GUJAPOLLO.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.48% | |
BAYERCROP.NS | Dividend Junior | 2023-08-03 | Annually | 15 | 1.25% | |
PRESSMN.NS | Dividend Knight | 2023-07-07 | Annually | 12 | 2.06% | |
KAMDHENU.NS | Dividend Junior | 2023-08-14 | Sporadic | 17 | 0.32% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -8.99 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.158 | 1.200 | -5.26 | -6.31 | [0 - 0.3] |
returnOnEquityTTM | 0.101 | 1.500 | 9.99 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.0559 | 0.800 | -4.72 | -3.78 | [1 - 3] |
quickRatioTTM | 0.00970 | 0.800 | -4.65 | -3.72 | [0.8 - 2.5] |
cashRatioTTM | 0.0000001 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.221 | -1.500 | 6.31 | -9.47 | [0 - 0.6] |
interestCoverageTTM | -0.000519 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.162 | 2.00 | -0.0540 | -0.108 | [0 - 30] |
freeCashFlowPerShareTTM | -0.162 | 2.00 | -0.0809 | -0.162 | [0 - 20] |
debtEquityRatioTTM | -0.130 | -1.500 | -0.520 | 0.781 | [0 - 2.5] |
grossProfitMarginTTM | 0.357 | 1.000 | 7.39 | 7.39 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.00649 | 1.000 | -2.13 | -2.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00450 | 1.000 | -1.136 | -1.136 | [0.2 - 2] |
assetTurnoverTTM | 0.0175 | 0.800 | -3.22 | -2.57 | [0.5 - 2] |
Total Score | -1.062 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.113 | 1.000 | -0.112 | 0 | [1 - 100] |
returnOnEquityTTM | 0.101 | 2.50 | 9.99 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.162 | 2.00 | -0.0540 | -0.162 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.162 | 2.00 | -0.0540 | -0.108 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00111 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0568 | 1.000 | -3.92 | 0 | [0.1 - 0.5] |
Total Score | 0.0762 |
Parenteral Drugs (India)
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators